(Q35953776)

11 August 2017

1 reference

title

Significance of the cytokine interferon gamma in clinical dermatology (English)

1 reference

11 August 2017

Grassegger A

1

1 reference

11 August 2017

Höpfl R

series ordinal

2

1 reference

11 August 2017

publication date

1 November 2004

1 reference

Clinical and Experimental Dermatology

11 August 2017

published in

1 reference

11 August 2017

volume

29

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

584-588

1 reference

Cellular responses to interferon-gamma

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2004.01652.X

Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2004.01652.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2004.01652.X

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2004.01652.X

Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2004.01652.X

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2004.01652.X

10.1111/J.1365-2230.2004.01652.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference